lunes, 18 de agosto de 2014

Breast-Cancer Risk in Families with Mutations in PALB2 — NEJM

Breast-Cancer Risk in Families with Mutations in PALB2 — NEJM

Genomics & Health Impact Update

Hereditary Breast & Ovarian Cancer: New Genetic Insights & Implementation

hands holding a pink ribbon with a double helix in the background
New findings: Breast-cancer risk in families with mutations in PALB2External Web Site Icon

Antoniou AC, et al. New England Journal of Medicine2014 Aug 13
PALB2 mutations and breast-cancer risk External Web Site Icon

Evans MK & Longo DL N Engl J Med 2014 Aug;371(6):566-8
Study shows third gene as indicator for breast cancer,External Web Site Icon by Nicholas Bakalar, The New York Times, Aug 6
Breast-cancer predisposition in multiple endocrine neoplasia type 1External Web Site Icon

N Engl J Med 2014; 371:583-584 August 7, 2014
It's rare, but yet another breast cancer gene identified,External Web Site Icon Medscape, Aug 11 [by free subscription only]
CDC sponsored study findings: Implementing a screening tool for identifying patients at risk for hereditary breast and ovarian cancer: A statewide initiative.External Web Site Icon

Brannon Traxler L, et al. Ann Surg Oncol. 2014 Jul 22
CDC initiative Know:BRCA. In the US, 9,000 women younger than 40 years are diagnosed every year with breast cancer.  In this younger group, breast cancer is generally more aggressive, found at a later stage, and has lower survival rates
CDC BRCA assessment tool for women: The Know:BRCA Assessment can help you assess your risk of having a BRCA mutation. Learning your risk can help you and your doctor make important decisions for your health

No hay comentarios:

Publicar un comentario